Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Name: Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Published: 2008
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID) · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

hiv infections, hiv integrase inhibitors, hiv nucleoside reverse transcriptase inhibitors, treatment naive, viral load, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Related documents